Results 11 to 20 of about 30,043 (228)

Quantization and variational problem of the Gubser-Rocha Einstein-Maxwell-Dilaton model, conformal and non-conformal deformations, and its proper thermodynamics

Journal of High Energy Physics, 2023
We show that the strongly coupled field theory holographically dual to the Gubser-Rocha anti-de-Sitter Einstein-Maxwell-Dilaton theory describes not a single non-trivial AdS2 IR fixed point, but a one-parameter family.
Nicolas Chagnet, Floris Balm, Koenraad Schalm   +2 more
doaj   +1 more source

Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline

TH Open, 2021
Background Dentoalveolar procedures in immune thrombocytopenia (ITP) pose a risk of bleeding due to thrombocytopenia and infection due to immunosuppressive treatments.
Wobke E. M. van Dijk, Robert J. J. van Es, Maria E. P. Correa, Roger E. G. Schutgens, Karin P. M. van Galen   +4 more
doaj   +1 more source

Isolated zeros destroy Fermi surface in holographic models with a lattice

Journal of High Energy Physics, 2020
We study the fermionic spectral density in a strongly correlated quantum system described by a gravity dual. In the presence of periodically modulated chemical potential, which models the effect of the ionic lattice, we explore the shapes of the ...
Floris Balm, Alexander Krikun, Aurelio Romero-Bermúdez, Koenraad Schalm, Jan Zaanen   +4 more
doaj   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial. [PDF]

Am J Hematol
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Röth A, Barcellini W, Ademokun C, Jang J, Lozano ML, Ferreiras DV, Pascual-Izquierdo C, Chitnis S, Matviykiv S, Vitaliti A, Chen C, Katsanou V, Chawla R, Al-Samkari H.   +13 more
europepmc   +2 more sources

Lenalidomide-Associated ITP [PDF]

Case Reports in Hematology, 2011
Lenalidomide is a potent immunomodulatory agent being used increasingly for treatment of hematologic malignancies including multiple myeloma and myelodysplasia. The common toxicities of lenalidomide, including dose-limiting myelosuppression, are well described.
Christina I. Herold, Cristina Gasparetto, Gowthami M. Arepally   +2 more
openaire   +3 more sources

Bleeding Diseases in Orthopedic Clinical Approach [PDF]

Гений oртопедии, 2020
Aim Bleeding diseases are rarely studied as complications of an orthopedic surgical procedure with postsurgical bleeding. This study aims to present a retrospective cohort-study about the approach to bleeding disorders in an ordinary orthopedic clinic ...
Kadri Yildiz, Vahit Yildiz
doaj   +1 more source

PENGARUH PENAMBAHAN SODA DAN ASAM JAWA (Tamarindus indicia L.) PADA MINUMAN TRADISIONAL KUNYIT ASEM TERHADAP DAYA TERIMA KONSUMEN BERDASARKAN MUTU DAN ORGANOLEPTIKNYA

AGROMIX, 2018
Kunyit asam merupakan minuman tradisioan yang memiliki manfaat antioksidan, antimikroba, sumber protein, serta vitamin A. penambahan carbonated (soda) bertujuan untuk memberikan inovasi baru pada pembuatan minuman tradisional.
Firduasi Puji Suryana, Dimas Hari Purnomo, Ana Ummu Mas’ulah, Wike Adhi Anggono, Rekna Wahyuni   +4 more
doaj   +1 more source

Cognitive Outcome After Deep Brain Stimulation for Refractory Obsessive–Compulsive Disorder: A Systematic Review

Neuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Introduction Deep brain stimulation (DBS) is an effective treatment for refractory obsessive–compulsive disorder (OCD). Neuropsychological assessment contributes to DBS treatment in several ways: it monitors the cognitive safety of the treatment, identifies beneficial or detrimental cognitive side effects and it could aid to explain ...
Tim A. M. Bouwens van der Vlis, Annelien Duits, Mégan M. G. H. van de Veerdonk, Anne E. P. Mulders, Koen R. J. Schruers, Yasin Temel, Linda Ackermans, Albert F. G. Leentjens   +7 more
wiley   +1 more source

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report

TH Open, 2021
Novel mRNA and vector-based covid-19 vaccinations have shown high efficacy in preventing symptomatic COVID-19 infections. Compared with the number of performed vaccinations, rates of severe side effects seem low.
Martin Koch, Sybille Fuld, Jan M. Middeke, Julia Fantana, Simone von Bonin, Jan Beyer-Westendorf   +5 more
doaj   +1 more source

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review

Platelets, 2021
Previous meta-analyses reported discordant results on the efficacy and safety of thrombopoietin receptor agonists (TPO-RA) as second-line treatment in patients with immune thrombocytopenia (ITP). We conducted a meta-analysis of primary ITP treatment with
Simone Birocchi, Gian Marco Podda, Marco Manzoni, Giovanni Casazza, Marco Cattaneo   +4 more
doaj   +1 more source